Free Trial

AdvisorShares Psychedelics ETF Rating

AdvisorShares Psychedelics ETF logo
$11.91 -0.10 (-0.83%)
(As of 11/21/2024 ET)

AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

PSIL Aggregate Rating

Moderate Buy
2.90

Holdings in PSIL have an aggregate rating of Moderate Buy based on 80 analyst ratings issued in the past year covering 11 companies (59.6% of the portfolio).

PSIL Aggregate Price Target

$11.91
High Prediction$11.91
Average Prediction$11.91
Low Prediction$11.91

Holdings in PSIL have an aggregate price target of $11.91 and a range of $11.91 to $11.91 covering 11 companies (59.6% of the portfolio).

PSIL Consensus Ratings of Holdings

Strong Buy
1 Strong Buy rating(s)
Buy
6 Buy rating(s)
Moderate Buy
2 Moderate Buy rating(s)
Hold
2 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by AdvisorShares Psychedelics ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 11 PSIL Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
9.32%
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
$7.04
-6.4%
2.4318 of 5 stars
3.25$25.38 260.7%12
6.08%
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
$1.23
+1.7%
2.0075 of 5 stars
3.33$31.50 2,461.0%3
5.41%
GH Research PLC stock logo
GHRS
GH Research
$9.62
-12.1%
1.8331 of 5 stars
3.00$35.67 270.8%3Analyst Forecast
News Coverage
5.20%
Alkermes plc stock logo
ALKS
Alkermes
$27.79
-0.4%
4.8279 of 5 stars
2.58$35.42 27.4%12Positive News
5.03%
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
$2.75
-3.5%
4.0959 of 5 stars
2.00$7.50 172.7%2
5.02%
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
$4.47
-4.3%
2.8542 of 5 stars
3.00$30.67 586.8%7Short Interest ↓
4.99%
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
$1.52
-5.0%
2.3827 of 5 stars
3.00$9.00 494.1%4Analyst Forecast
Analyst Revision
4.74%
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
$4.85
-1.2%
4.3753 of 5 stars
2.00$12.83 164.6%21Analyst Forecast
News Coverage
Gap Up
4.68%
Intra-Cellular Therapies, Inc. stock logo
ITCI
Intra-Cellular Therapies
$85.45
-0.2%
4.4844 of 5 stars
2.85$97.23 13.8%13
4.61%
Enveric Biosciences, Inc. stock logo
ENVB
Enveric Biosciences
$0.34
-2.9%
2.5316 of 5 stars
3.00$10.00 2,878.0%1Gap Down
4.56%
Vistagen Therapeutics, Inc. stock logo
VTGN
Vistagen Therapeutics
$2.54
-2.7%
3.7849 of 5 stars
3.50$15.00 490.6%2Positive News

This page (NYSEARCA:PSIL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners